Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities

SIMPLE SUMMARY: Now that low-intensity therapies, such as DNA methyltransferase inhibitors and venetoclax, have emerged as the leading options for elderly patients, it is increasingly crucial to consider the patient’s age and comorbidities when selecting therapy. In this article, we initially review...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshikawa, Gaku, Sasaki, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136601/
https://www.ncbi.nlm.nih.gov/pubmed/37190327
http://dx.doi.org/10.3390/cancers15082399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136601/
https://www.ncbi.nlm.nih.gov/pubmed/37190327
http://dx.doi.org/10.3390/cancers15082399

Ejemplares similares